Entries by Phil Case

AnPac Bio Completed 1st Half Year with Increased ASP and Revenue

FOR IMMEDIATE RELEASE AnPac Bio Completed 1st Half Year with Increased ASP and Revenue San Jose, CA, July 13, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, pre-announced certain results […]

AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening

FOR IMMEDIATE RELEASE AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening San Jose, CA, June 26, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations […]

AnPac Bio Launches New Immunology Test Product Line

FOR IMMEDIATE RELEASE AnPac Bio Launches New Immunology Test Product Line San Jose, CA, June 22, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that  the Company launched […]

AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening

FOR IMMEDIATE RELEASE AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening San Jose, CA, June 19, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that […]

AnPac Bio Announces Appointment of New Chief Financial Officer

San Jose, CA, June 2, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced the appointment of Mr. Jinqiu (Edwards) Tang as the Chief Financial Officer of the Company, […]

AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States

AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent  Granted This Year in the United States San Jose, CA, May 26, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and […]

AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019  

AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019   Continued annual revenue growth Number of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-year Continued to gain customers and increase the acceptance of our cancer risk assessment tests San Jose, CA, May 18, 2020 – AnPac Bio-Medical Science Co., […]

20-F 2019 Filing

FOR IMMEDIATE RELEASE San Jose, CA., May 18, 2020—AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it has filed its annual report on Form 20-F for the fiscal year ended […]

AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States

FOR IMMEDIATE RELEASE AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States San Jose, CA, May 11, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening […]

AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists

AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists SAN JOSE, Calif., March 27, 2020 — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that its San […]

©2021 Anpac Bio-Medical Science Co., Ltd.